{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:52:11Z","timestamp":1791021131166,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.clineuro.2022.107189","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T13:11:10Z","timestamp":1645708270000},"page":"107189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Dabigatran versus aspirin for stroke prevention after cryptogenic stroke with patent foramen ovale: A prospective study"],"prefix":"10.1016","volume":"215","author":[{"given":"Shumin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongchun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peichu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clineuro.2022.107189_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1212\/CON.0000000000000832","article-title":"The evolving concept of cryptogenic stroke","volume":"26","author":"Kamel","year":"2020","journal-title":"Continuum"},{"issue":"8","key":"10.1016\/j.clineuro.2022.107189_bib2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/WNL.0000000000002961","article-title":"Practice advisory: recurrent stroke with patent foramen ovale (update of practice parameter): report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"87","author":"Mess\u00e9","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.clineuro.2022.107189_bib3","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00415-018-8865-0","article-title":"Patent foramen ovale and stroke","volume":"265","author":"Miranda","year":"2018","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.clineuro.2022.107189_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.clineuro.2022.107189_bib5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107189_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jamaneurol.2019.2984","article-title":"Association between low-dose rivaroxaban with or without aspirin and ischemic stroke subtypes: a secondary analysis of the COMPASS trial","volume":"77","author":"Perera","year":"2020","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107189_bib7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.clineuro.2022.107189_bib8","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.clineuro.2022.107189_bib9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107189_bib10","article-title":"A comparison of methods to determine patent foramen ovale size","volume":"96","author":"Kumar","year":"2020","journal-title":"Catheter. Cardiovasc. Interv.: Off. J. Soc. Card. Angiogr. Interv."},{"issue":"7","key":"10.1016\/j.clineuro.2022.107189_bib11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/jamaneurol.2020.0458","article-title":"Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke","volume":"77","author":"Elgendy","year":"2020","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107189_bib12","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/STROKEAHA.120.031237","article-title":"Dabigatran or aspirin after embolic stroke of undetermined source in patients with patent foramen ovale: results from RE-SPECT ESUS","volume":"52","author":"Diener","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2022.107189_bib13","doi-asserted-by":"crossref","unstructured":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke, N. Engl. J. Med., vol. 382(10), 2020, 978. \u3008https:\/\/doi.org\/10.1056\/NEJMx200001\u3009.","DOI":"10.1056\/NEJMx200001"},{"issue":"2","key":"10.1016\/j.clineuro.2022.107189_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1212\/CON.0000000000000833","article-title":"Ischemic stroke in young adults","volume":"26","author":"Putaala","year":"2020","journal-title":"Continuum"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107189_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.clineuro.2022.107189_bib16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","article-title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial","volume":"17","author":"Kasner","year":"2018","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107189_bib17","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1007\/s10072-020-04388-4","article-title":"Aspirin or anticoagulation after cryptogenic stroke with patent foramen ovale: systematic review and meta-analysis of randomized controlled trials","volume":"41","author":"Romoli","year":"2020","journal-title":"Neurol. Sci.: Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"issue":"35","key":"10.1016\/j.clineuro.2022.107189_bib18","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/eurheartj\/ehv252","article-title":"Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis","volume":"36","author":"Kent","year":"2015","journal-title":"Eur. Heart J."},{"issue":"21","key":"10.1016\/j.clineuro.2022.107189_bib19","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1212\/WNL.0000000000001007","article-title":"Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke","volume":"83","author":"Thaler","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.clineuro.2022.107189_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.medcli.2017.11.042","article-title":"Direct oral anticoagulants: an update","volume":"151","author":"Franco Moreno","year":"2018","journal-title":"Med. Clin."},{"issue":"8","key":"10.1016\/j.clineuro.2022.107189_bib21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.2015.0846","article-title":"Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage","volume":"313","author":"Kuramatsu","year":"2015","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107189_bib22","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/STROKEAHA.116.016275","article-title":"Rivaroxaban versus dabigatran or warfarin in real-world studies of stroke prevention in atrial fibrillation: systematic review and meta-analysis","volume":"48","author":"Bai","year":"2017","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.clineuro.2022.107189_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaneurol.2019.0591","article-title":"Tailoring the approach to embolic stroke of undetermined source: a review","volume":"76","author":"Kamel","year":"2019","journal-title":"JAMA Neurol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:39:28Z","timestamp":1759588768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846722000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":23,"alternative-id":["S0303846722000701"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107189","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dabigatran versus aspirin for stroke prevention after cryptogenic stroke with patent foramen ovale: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107189"}}